Sofie Haglund
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Inflammatory Bowel Disease
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Genetics 5
- Inflammatory Bowel Disease 5
- Co-authors
- Sven H. Almer (7 shared papers)Curt O. Peterson (5 shared papers)Jan Taipalensuu (3 shared papers)Malin Lindqvist Appell (2 shared papers)Margit Müller-Bardorff (2 shared papers)Hugo Albert Katus (2 shared papers)Jan Söderman (4 shared papers)W. Gerhardt (2 shared papers)
- Journals
- Clinical Chemistry (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)PLoS ONE (2 papers)Scandinavian Journal of Clinical and Laboratory Investigation (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SwedenGermanyUnited Kingdom
In The Last Decade
Sofie Haglund
16 papers receiving 351 citations
Peers
Comparison fields: 5 of 40
- Pharmacology 152
- Genetics 78
- Cardiology and Cardiovascular Medicine 64
- Physiology 59
- Applied Microbiology and Biotechnology 3
Countries citing papers authored by Sofie Haglund
This map shows the geographic impact of Sofie Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Haglund more than expected).
Fields of papers citing papers by Sofie Haglund
This network shows the impact of papers produced by Sofie Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Haglund. The network helps show where Sofie Haglund may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Haglund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 87 | |
| 2 | 2004 | 68 | |
| 3 | 2004 | 59 | |
| 4 | 2007 | 49 | |
| 5 | 2011 | 23 | |
| 6 | 2013 | 15 | |
| 7 | 2017 | 14 | |
| 8 | 2021 | 10 | |
| 9 | 2023 | 10 | |
| 10 | 2004 | 9 | |
| 11 | More on troponin assays and heparin - Response | 2001 | 7 |
| 12 | 2017 | 5 | |
| 13 | 2020 | 4 | |
| 14 | 2009 | 3 | |
| 15 | 2017 | 3 | |
| 16 | 2025 | 1 |
About Sofie Haglund
Sofie Haglund is a scholar working on Pharmacology, Genetics, Parasitology, Cardiology and Cardiovascular Medicine and Physiology, having authored 16 papers that have together received 367 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Inflammatory Bowel Disease (5 papers), Vector-borne infectious diseases (2 papers), Clinical Laboratory Practices and Quality Control (2 papers), Acute Myocardial Infarction Research (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Influenza Virus Research Studies (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pharmacology (152 citations), Genetics (78 citations), Cardiology and Cardiovascular Medicine (64 citations), Physiology (59 citations) and Applied Microbiology and Biotechnology (3 citations). Sofie Haglund has collaborated with scholars based in Sweden, Germany and United Kingdom. Frequent co-authors include Sven H. Almer, Curt O. Peterson, Jan Taipalensuu, Malin Lindqvist Appell, Margit Müller-Bardorff, Hugo Albert Katus, Jan Söderman, W. Gerhardt, Gunnar Nordin and Erik Hertervig. Their work appears in journals such as Clinical Chemistry, European Journal of Clinical Microbiology & Infectious Diseases, PLoS ONE, Scandinavian Journal of Clinical and Laboratory Investigation and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.